Quoin Pharmaceuticals, Ltd. 8-K

What Happened
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) announced its fourth quarter and fiscal year 2025 financial results and filed an 8-K reporting those results on March 26, 2026. The company attached a press release as Exhibit 99.1 to the filing, which is incorporated by reference in the 8-K.

Key Details

• Filing date: March 26, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Event reported: Announcement of fourth quarter and full fiscal year 2025 financial results.
• Supporting document: Press release attached as Exhibit 99.1 to the 8-K.
• The 8-K references the press release for the detailed financial information (figures and metrics are provided in the attached release).

Why It Matters
This filing signals that Quoin has released its latest earnings and year-end performance, which are material to investors evaluating revenue, profitability, cash position, and near-term prospects. The 8-K itself points investors to the attached press release for the specific numbers and any management commentary or guidance—review that Exhibit 99.1 for the full financials and context before making investment decisions.